444
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

DFT, Molecular Docking and ADME Studies of Thiazolidinones as Tyrosinase Inhibitors

, ORCID Icon, ORCID Icon, , &
Pages 6750-6765 | Received 11 Jul 2022, Accepted 08 Sep 2022, Published online: 21 Sep 2022

References

  • T. Pillaiyar, V. Namasivayam, M. Manickam, and S.-H. Jung, “Inhibitors of Melanogenesis: An Updated Review,” Journal of Medicinal Chemistry 61, no. 17 (2018): 7395–418.
  • J. Akter, M. Islam, M. Hossain, and K. Takara, “Anti-Tyrosinase Properties of Different Species of Turmeric and Isolation of Active Compounds from Curcuma Amada,” Medicinal Chemistry Research 30, no. 9 (2021): 1669–76.
  • A. Baldi, “Computational Approaches for Drug Design and Discovery: An Overview,” Systematic Reviews in Pharmacy 1, no. 1 (2010): 99.
  • T. Pillaiyar, M. Manickam, and V. Namasivayam, “Skin Whitening Agents: Medicinal Chemistry Perspective of Tyrosinase Inhibitors,” Journal of Enzyme Inhibition and Medicinal Chemistry 32, no. 1 (2017): 403–25.
  • N. Baurin, E. Arnoult, T. Scior, Q. Do, and P. Bernard, “Preliminary Screening of Some Tropical Plants for anti-Tyrosinase Activity,” Journal of Ethnopharmacology 82, no. 2–3 (2002): 155–8.
  • S. Halaouli, M. Asther, J.C. Sigoillot, M. Hamdi, and A. Lomascolo, “Fungal Tyrosinases: new Prospects in Molecular Characteristics, Bioengineering and Biotechnological Applications,” Journal of Applied Microbiology 100, no. 2 (2006): 219–32.
  • P. García-Molina, F. García-Molina, J.A. Teruel-Puche, J.N. Rodríguez-López, F. García-Cánovas, and J.L. Muñoz-Muñoz, “Considerations about the Kinetic Mechanism of Tyrosinase in Its Action on Monophenols: A Review,” Molecular Catalysis 518 (2022): 112072.
  • Z.D. Zhou, S.P. Xie, W.T. Saw, P.G.H. Ho, H.Y. Wang, L. Zhou, Y. Zhao, and E.K. Tan, “The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD),” Cells 8, no. 8 (2019): 911.
  • S. Zolghadri, A. Bahrami, M.T. Hassan Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas, and A.A. Saboury, “A Comprehensive Review on Tyrosinase Inhibitors,” Journal of Enzyme Inhibition and Medicinal Chemistry 34, no. 1 (2019): 279–309.
  • M. Muthukkumar, T. Bhuvaneswari, G. Venkatesh, C. Kamal, P. Vennila, S. Armaković, S.J. Armaković, Y. Sheena Mary, and C. Yohannan. Panicker, “Synthesis, Characterization and Computational Studies of Semicarbazide Derivative,” Journal of Molecular Liquids 272 (2018): 481–95.
  • G. Venkatesh, Y. Sheena Mary, Y. Shymamary, V. Palanisamy, and M. Govindaraju, “Quantum Chemical and Molecular Docking Studies of Some Phenothiazine Derivatives,” Journal of Applied Organometallic Chemistry 1 (2021): 148–58.
  • P. Bajpai, S. Jain, and A. Choubey, “Thiazolidine, a Versatile Ring in the Treatment of Various Diseases: A Systematic Review,” Asian Journal of Research in Chemistry 13, no. 4 (2020): 283–6.
  • V. Asati, and S.K. Bharti, “Design, Synthesis and Molecular Modeling Studies of Novel Thiazolidine-2, 4-Dione Derivatives as Potential anti-Cancer Agents,” Journal of Molecular Structure 1154 (2018): 406–17.
  • M.C.V. de Oliveira, D.C. Viana, A.A. Silva, M.C. Pereira, F.S. Duarte, M.G. Pitta, I.R. Pitta, and M.G. Pitta, “Synthesis of Novel Thiazolidinic-Phthalimide Derivatives Evaluated as New Multi-Target Antiepileptic Agents,” Bioorganic Chemistry 119 (2022): 105548.
  • G.N. Tageldin, S.M. Fahmy, H.M. Ashour, M.A. Khalil, R.A. Nassra, and I.M. Labouta, “Design, Synthesis and Evaluation of Some Pyrazolo [3, 4-d] Pyrimidines as anti-Inflammatory Agents,” Bioorganic Chemistry 78 (2018): 358–71.
  • Z. Ngaini, A.N. Abd Halim, F. Rasin, and W.S.H. Wan Zullkiplee, “Synthesis and Structure–Activity Relationship Studies of Mono-and Bis-Thiourea Derivatives Featuring Halogenated Azo Dyes with Antimicrobial Properties,” Phosphorus, Sulfur, and Silicon and the Related Elements (2022): 1–9. doi: 10.1080/10426507.2022.2046577
  • A.S. Chavan, A.S. Kharat, M.R. Bhosle, and R.A. Mane, “Baker’s Yeast Catalyzed One-Pot Synthesis of Bioactive 2-[Benzylidene (or Pyrazol-4-Ylmethylene) Hydrazono]-1, 3-Thiazolidin-4-One-5-yl-Acetic Acids,” Heterocyclic Communications 24, no. 2 (2018): 103–7.
  • P.S. Kulkarni, S.N. Karale, A.U. Khandebharad, B.R. Agrawal, and S.R. Sarda, “Design, Synthesis, and Biological Evaluation of Newer Arylidene Incorporated 4-Thiazolidinones Derivatives as Potential Antimicrobial Agents,” Polycyclic Aromatic Compounds 42, no. 5 (2022): 2031–44.
  • R. Singh, S. Ahmad. Ganaie, A. Singh, and A. Chaudhary, “Carbon-SO3H Catalyzed Expedient Synthesis of New Spiro-[Indeno [1, 2-b] Quinoxaline-[11, 2′]-Thiazolidine],” Synthetic Communications 49, no. 1 (2019): 80–93.
  • M.Y. Sameeh, M.M. Khowdiary, H.S. Nassar, M.M. Abdelall, H.H. Amer, A. Hamed, and A.A. Elhenawy, “Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and anti-Diabetic Evaluation,” Molecules 27, no. 3 (2022): 830.
  • E.A. Fayed, E.M.E. Al-Arab, A.S. Saleh, A.H. Bayoumi, and Y.A. Ammar, “Design, Synthesis, in Silico Studies, In Vivo and In Vitro Assessment of Pyridones and Thiazolidinones as anti-Inflammatory, Antipyretic and Ulcerogenic Hits,” Journal of Molecular Structure 1260 (2022): 132839.
  • Hassan Hammoud, Khadija Elhabazi, Raphäelle Quillet, Isabelle Bertin, Valérie Utard, Emilie Laboureyras, Jean-Jacques Bourguignon, Frédéric Bihel, Guy Simonnet, Frédéric Simonin, et al., “Aminoguanidine Hydrazone Derivatives as Nonpeptide NPFF1 Receptor Antagonists Reverse Opioid Induced Hyperalgesia,” ACS Chemical Neuroscience 9, no. 11 (2018): 2599–609.,
  • A.R. Nath, W.A. Yehye, and M.R.B. Johan, “Butylated Hydroxy Benzylidene Ring: An Important Moiety for Antioxidant Synergism of Semicarbazones,” Journal of Thermal Analysis and Calorimetry 146, no. 5 (2021): 2101–14.
  • F.M. Aqlan, A.S. Al-Bogami, N.F. Alqahtani, M.Y. Wani, and S.A. Khan, “Thiazolidinone: A Structural Motif of Great Synthetic and Biological Importance,” Journal of Molecular Structure 1250 (2022): 131771.
  • N. Trotsko, “Antitubercular Properties of Thiazolidin-4-Ones–A Review,” European Journal of Medicinal Chemistry 215 (2021): 113266.
  • A. Petrou, P. Eleftheriou, A. Geronikaki, M.G. Akrivou, and I. Vizirianakis, “Novel Thiazolidin-4-Ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase,” Molecules 24, no. 21 (2019): 3821.
  • H.R. Addanki, M.R. Vallabhaneni, S. Chennamsett, P. Pullagura, S.R. Sagurthi, and V.R. Pasupuleti, “An in Silico ADMET, Molecular Docking Study and Microwave-Assisted Synthesis of New Phosphorylated Derivatives of Thiazolidinedione as Potential Anti-Diabetic Agents,” Synthetic Communications 52, no. 2 (2022): 300–15.
  • P. Marshall, and D. Vallance, “Derivatives of Succinimide, Glutarimide, Thiazolidinedione and Methanol, and Some Miscellaneous Compounds,” The Journal of Pharmacy and Pharmacology 6, no. 10 (1954): 740–6.
  • A. Santos, D.O. Magro, R. Evangelista-Poderoso, and M.J.A. Saad, “Diabetes, Obesity, and Insulin Resistance in COVID-19: Molecular Interrelationship and Therapeutic Implications,” Diabetology & Metabolic Syndrome 13, no. 1 (2021): 14.
  • S. Mutahir, M.A. Khan, I.U. Khan, M. Yar, M. Ashraf, S. Tariq, R-l Ye, and B-j Zhou, “Organocatalyzed and Mechanochemical Solvent-Free Synthesis of Novel and Functionalized Bis-Biphenyl Substituted Thiazolidinones as Potent Tyrosinase Inhibitors: SAR and Molecular Modeling Studies,” European Journal of Medicinal Chemistry 134 (2017): 406–14.
  • K.R. Kim, H.J. Kim, S.K. Lee, G.T. Ma, K.K. Park, and W.Y. Chung, “15-Deoxy-δ12, 14-Prostaglandin j2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss,” PLoS One 10, no. 4 (2015): e0122764.
  • G. Venkatesh, Y. Sixto-López, P. Vennila, Y.S. Mary, J. Correa-Basurto, Y.S. Mary, and A. Manikandan, “An Investigation on the Molecular Structure, Interaction with Metal Clusters, Anti-Covid-19 Ability of 2-Deoxy-D-Glucose: DFT Calculations, MD and Docking Simulations,” Journal of Molecular Structure 1258 (2022): 132678.
  • G. Raja, G. Venkatesh, J.S. Al-Otaibi, P. Vennila, Y.S. Mary, and Y. Sixto-López, “Synthesis, Characterization, Molecular Docking and Molecular Dynamics Simulations of Benzamide Derivatives as Potential anti-Ovarian Cancer Agents,” Journal of Molecular Structure 1269 (2022): 133785.
  • K. Eun Lee, S. Bharadwaj, U. Yadava, and S. Gu Kang, “Evaluation of Caffeine as Inhibitor against Collagenase, Elastase and Tyrosinase Using In Silico and In Vitro Approach,” Journal of Enzyme Inhibition and Medicinal Chemistry 34, no. 1 (2019): 927–36.
  • S.A. Shehzadi, A. Saeed, F. Perveen, P.A. Channar, I. Arshad, Q. Abbas, S. Kalsoom, S. Yousaf, and J. Simpson, “Identification of two novel thiazolidin-2-imines as tyrosinase inhibitors: Synthesis, crystal structure, molecular docking and DFT studies.” Heliyon 8, no. 8 (2022): e10098.
  • B. Steinfeld, J. Scott, G. Vilander, L. Marx, M. Quirk, J. Lindberg, and K. Koerner, “The Role of Lean Process Improvement in Implementation of Evidence-Based Practices in Behavioral Health Care,” The Journal of Behavioral Health Services & Research 42, no. 4 (2015): 504–18.
  • G. Ahmad, N. Rasool, A. Mubarik, A.F. Zahoor, M.A. Hashmi, M. Zubair, M. Bilal, M. Hussien, M.S. Akhtar, and S. Haider, “Facile Synthesis of 5-Aryl-N-(Pyrazin-2-yl) Thiophene-2-Carboxamides via Suzuki Cross-Coupling Reactions, Their Electronic and Nonlinear Optical Properties through DFT Calculations,” Molecules 26, no. 23 (2021): 7309.
  • M.A. Albo Hay Allah, A.A. Balakit, H.I. Salman, A.A. Abdulridha, and Y. Sert, “New Heterocyclic Compound as Carbon Steel Corrosion Inhibitor in 1 M H2SO4, High Efficiency at Low Concentration: Experimental and Theoretical Studies,” Journal of Adhesion Science and Technology (2022): 1–23. doi: 10.1080/01694243.2022.2034588
  • G. Venkatesh, C. Kamal, P. Vennila, M. Govindaraju, Y.S. Mary, S. Armakovic, S.J. Armakovic, S. Kaya, and C.Y. Panicker, “Molecular Dynamic Simulations, ALIE Surface, Fukui Functions Geometrical, Molecular Docking and Vibrational Spectra Studies of Tetra Chloro p and m-Xylene,” Journal of Molecular Structure 1171 (2018): 253–67.
  • Katarzyna Piechowska, Magdalena Mizerska-Kowalska, Barbara Zdzisińska, Joanna Cytarska, Angelika Baranowska-Łączkowska, Karol Jaroch, Kamil Łuczykowski, Wojciech Płaziński, Barbara Bojko, Stefan Kruszewski, et al., “Tropinone-Derived Alkaloids as Potent Anticancer Agents: Synthesis, Tyrosinase Inhibition, Mechanism of Action, DFT Calculation, and Molecular Docking Studies,” International Journal of Molecular Sciences 21, no. 23 (2020): 9050.
  • P.A. Channar, A. Saeed, F.A. Larik, M. Rafiq, Z. Ashraf, F. Jabeen, and T.A. Fattah, “Synthesis, Computational Studies and Enzyme Inhibitory Kinetics of Substituted Methyl [2-(4-Dimethylamino-Benzylidene)-Hydrazono)-4-Oxo-Thiazolidin-5-Ylidene] Acetates as Mushroom Tyrosinase Inhibitors,” Bioorganic & Medicinal Chemistry 25, no. 21 (2017): 5929–38.
  • A.A. Abdulridha, M.A.A.H. Allah, S.Q. Makki, Y. Sert, H.E. Salman, and A.A. Balakit, “Corrosion Inhibition of Carbon Steel in 1 M H2SO4 Using New Azo Schiff Compound: Electrochemical, Gravimetric, Adsorption, Surface and DFT Studies,” Journal of Molecular Liquids 315 (2020): 113690.
  • Asim A. Balakit, Sajjad Q. Makki, Yusuf Sert, Fatih Ucun, Mohammed B. Alshammari, Pall Thordarson, and Gamal A. El-Hiti, “Synthesis, Spectrophotometric and DFT Studies of New Triazole Schiff Bases as Selective Naked-Eye Sensors for Acetate Anion,” Supramolecular Chemistry 32, no. 10 (2020): 519–26.
  • M. Gümüş, ŞN. Babacan, Y. Demir, Y. Sert, İ. Koca, and İ. Gülçin, “Discovery of Sulfadrug–Pyrrole Conjugates as Carbonic Anhydrase and Acetylcholinesterase Inhibitors,” Archiv Der Pharmazie 355, no. 1 (2022): 2100242.
  • N. Dege, H. Gökce, O.E. Doğan, G. Alpaslan, T. Ağar, S. Muthu, Y. Sert, Quantum Computational, Spectroscopic Investigations On N-(2-((2-Chloro-4, 5-Dicyanophenyl) Amino) Ethyl)-4-Methylbenzenesulfonamide by DFT/TD-DFT with Different Solvents, Molecular Docking and Drug-Likeness Researches,” Colloids and Surfaces A: Physicochemical and Engineering Aspects 638 (2022): 128311.
  • F.S. Tokalı, P. Taslimi, İH. Demircioğlu, K. Şendil, B. Tuzun, and İ. Gülçin, “Novel Phenolic Mannich Base Derivatives: Synthesis, Bioactivity, Molecular Docking, and ADME-Tox Studies,” Journal of the Iranian Chemical Society 19, no. 2 (2022): 563–77.
  • Y. Demir, “Naphthoquinones, Benzoquinones, and Anthraquinones: Molecular Docking, ADME and Inhibition Studies on Human Serum Paraoxonase‐1 Associated with Cardiovascular Diseases,” Drug Development Research 81, no. 5 (2020): 628–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.